These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8330800)

  • 1. [Effect of Y-25130, a selective 5-HT3 receptor antagonist, on the intestinal fluid secretion in rats].
    Ooe M; Asano K; Haga K; Setoguchi M
    Nihon Yakurigaku Zasshi; 1993 May; 101(5):299-307. PubMed ID: 8330800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins.
    Mourad FH; O'Donnell LJ; Dias JA; Ogutu E; Andre EA; Turvill JL; Farthing MJ
    Gut; 1995 Sep; 37(3):340-5. PubMed ID: 7590428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat.
    Turvill JL; Connor P; Farthing MJ
    Br J Pharmacol; 2000 Jul; 130(5):1031-6. PubMed ID: 10882387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT2 and 5-HT3 receptor subtypes mediate cholera toxin-induced intestinal fluid secretion in the rat.
    Beubler E; Horina G
    Gastroenterology; 1990 Jul; 99(1):83-9. PubMed ID: 2344945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin and granisetron reduce cholera toxin-induced hypersecretion in pig jejunum.
    Hansen MB; Skadhauge E
    Scand J Gastroenterol; 1994 Oct; 29(10):908-15. PubMed ID: 7839097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of serotonin antagonists on cholera-toxin-induced intestinal fluid secretion.
    Sjöqvist A; Cassuto J; Jodal M; Lundgren O
    Acta Physiol Scand; 1992 Jul; 145(3):229-37. PubMed ID: 1355626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic activity of Y-25130 on 5-HT3 receptors.
    Sato N; Sakamori M; Haga K; Takehara S; Setoguchi M
    Jpn J Pharmacol; 1992 Aug; 59(4):443-8. PubMed ID: 1331590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 5-hydroxytryptamine- and enterotoxin-induced fluid secretion by 5-HT receptor antagonists in the rat jejunum.
    Beubler E; Schirgi-Degen A; Gamse R
    Eur J Pharmacol; 1993 Aug; 248(2):157-62. PubMed ID: 8223962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin antagonists inhibit sennoside-induced fluid secretion and diarrhea.
    Beubler E; Schirgi-Degen A
    Pharmacology; 1993 Oct; 47 Suppl 1():64-9. PubMed ID: 8234443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Y-25130, a selective 5-hydroxytryptamine3 receptor antagonist, on gastric emptying in mice.
    Haga K; Asano K; Inaba K; Morimoto Y; Setoguchi M
    Arch Int Pharmacodyn Ther; 1994; 328(3):344-55. PubMed ID: 7625886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
    Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
    Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide counteracts 5-hydroxytryptamine- and cholera toxin-induced fluid secretion and enhances the effect of oral rehydration solution.
    Beubler E; Schirgi-Degen A
    Eur J Pharmacol; 1997 May; 326(2-3):223-8. PubMed ID: 9196275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High affinity binding of Y-25130 for serotonin 3 receptor].
    Sakamori M; Takehara S; Setoguchi M
    Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):137-42. PubMed ID: 1330854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition by Y-25130 of the von Bezold-Jarisch effect evoked by 5-HT or 2-methyl-5-HT in anesthetized rats].
    Inaba K; Morimoto Y; Fukuda T; Setoguchi M
    Nihon Yakurigaku Zasshi; 1991 Oct; 98(4):293-9. PubMed ID: 1802816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indomethacin, renzapride, methysergide, ketanserin, granisetron and citalopram on serotonin-induced fluid accumulation in pig jejunum.
    Hansen MB; Thørboll JE; Beubler E; Skadhauge E
    Physiol Res; 1994; 43(2):83-93. PubMed ID: 7918343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiemetic profile of Y-25130, a new selective 5-HT3 receptor antagonist.
    Fukuda T; Setoguchi M; Inaba K; Shoji H; Tahara T
    Eur J Pharmacol; 1991 Apr; 196(3):299-305. PubMed ID: 1654255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of 5-HT3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130.
    Yakushiji T; Akaike N
    Br J Pharmacol; 1992 Nov; 107(3):853-7. PubMed ID: 1472977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
    Fernández AG; Puig J; Beleta J; Doménech T; Bou J; Berga P; Gristwood RW; Roberts DJ
    Eur J Pharmacol; 1992 Nov; 222(2-3):257-64. PubMed ID: 1451737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-hydroxytryptamine (5-HT)3 receptor mechanisms in regulation of basal pancreatic secretion in conscious rats.
    Masuda M; Miyasaka K; Funakoshi A
    J Auton Nerv Syst; 1997 Jan; 62(1-2):58-62. PubMed ID: 9021650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.